{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:47:51Z","timestamp":1779364071433,"version":"3.53.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.neurobiolaging.2009.07.004","type":"journal-article","created":{"date-parts":[[2009,8,7]],"date-time":"2009-08-07T05:41:04Z","timestamp":1249623664000},"page":"547.e1-547.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["APOE dependent-association of PPAR-\u03b3 genetic variants with Alzheimer's disease risk"],"prefix":"10.1016","volume":"32","author":[{"given":"Onofre","family":"Combarros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloy","family":"Rodr\u00edguez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"V\u00e1zquez-Higuera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Infante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Berciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"S\u00e1nchez-Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/83348","article-title":"PPAR-\u03b1 and PPAR-\u03b3 activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway","volume":"7","author":"Chinetti","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000","article-title":"Inflammatory mechanisms in Alzheimer's disease: inhibition of \u03b2-amyloid-stimulated proinflammatory responses and neurotoxicity by PPAR\u03b3 agonists","volume":"20","author":"Combs","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib3","doi-asserted-by":"crossref","first-page":"29919","DOI":"10.1074\/jbc.M203934200","article-title":"Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice","volume":"277","author":"Gong","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ajmg.b.30503","article-title":"Candidate gene association study of insulin signaling genes and Alzheimer's disease: evidence for SOS2, PCK1, and PPARgamma as susceptibility loci","volume":"144B","author":"Hamilton","year":"2007","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neulet.2008.06.029","article-title":"Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease","volume":"441","author":"Helisalmi","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib6","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2007.04.016","article-title":"PPARs in the brain","volume":"1771","author":"Heneka","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib7","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1073\/pnas.94.6.2642","article-title":"Transcription factor NF-\u03baB is activated in primary neurons by amyloid \u03b2 peptides and in neurons surrounding early plaques from patients with Alzheimer disease","volume":"94","author":"Kaltschmidt","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000095857","article-title":"Association analysis of peroxisome proliferators-activated receptor gamma polymorphisms and late onset Alzheimer's disease in the Finnish population","volume":"22","author":"Koivisto","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nurt.2008.05.003","article-title":"PPAR\u03b3 agonists as therapeutics for the treatment of Alzheimer's disease","volume":"5","author":"Landreth","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer Disease","volume":"24","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.nbd.2005.05.002","article-title":"Apolipoprotein E4 enhances brain inflammation by modulation of the NF-\u03baB signaling cascade","volume":"20","author":"Ophir","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nn0403-345","article-title":"Alzheimer's disease: the cholesterol connection","volume":"6","author":"Puglielli","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1073\/pnas.0503839103","article-title":"Nonsteroidal anti-inflammatory drugs repress \u03b2-secretase gene promoter activity by the activation of PPAR\u03b3","volume":"103","author":"Sastre","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib15","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00702-004-0267-z","article-title":"Influence of peroxisome proliferators-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients","volume":"112","author":"Sauder","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.12.078","article-title":"The peroxisome proliferator-activated receptor gamma (PPAR-\u03b32) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenarians","volume":"1139","author":"Scacchi","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib17","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(05)70248-9","article-title":"Cholesterol in Alzheimer's disease","volume":"4","author":"Shobab","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.pneurobio.2008.04.006","article-title":"RAR\/RXR and PPAR\/RXR signalling in neurological and psychiatric diseases","volume":"85","author":"van Neerven","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib19","article-title":"The PPAR-gamma Pro12Ala polymorphism and risk of cognitive impairment in a longitudinal study","author":"West","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","article-title":"Inflammation in neurodegenerative disease: a double-edged sword","volume":"35","author":"Wyss-Coray","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.nbd.2007.10.005","article-title":"Cholesterol retention in Alzheimer's brain is responsible for high \u03b2- and \u03b3-secretase activities and A\u03b2 production","volume":"29","author":"Xiong","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2009.07.004_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neurobiolaging.2006.09.010","article-title":"PPAR-\u03b3 Pro12Ala genotype and risk of cognitive decline in elders","volume":"29","author":"Yaffe","year":"2008","journal-title":"Neurobiol. Aging"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458009002346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458009002346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:17:44Z","timestamp":1759317464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458009002346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0197458009002346"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.07.004","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOE dependent-association of PPAR-\u03b3 genetic variants with Alzheimer's disease risk","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}